Copyright Reports & Markets. All rights reserved.

Global Conjugate Vaccine Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Conjugate Vaccine Market Overview

    • 1.1 Product Overview and Scope of Conjugate Vaccine
    • 1.2 Conjugate Vaccine Segment by Type
      • 1.2.1 Global Conjugate Vaccine Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Hib Vaccine
      • 1.2.3 Meningococcal Vaccine
      • 1.2.4 Pneumococcal Vaccine
      • 1.2.5 Others
    • 1.3 Conjugate Vaccine Segment by End Users
      • 1.3.1 Conjugate Vaccine Sales Comparison by End Users: 2020 VS 2026
      • 1.3.2 Children
      • 1.3.3 Adult
    • 1.4 Global Conjugate Vaccine Market Size Estimates and Forecasts
      • 1.4.1 Global Conjugate Vaccine Revenue 2015-2026
      • 1.4.2 Global Conjugate Vaccine Sales 2015-2026
      • 1.4.3 Conjugate Vaccine Market Size by Region: 2020 Versus 2026

    2 Global Conjugate Vaccine Market Competition by Manufacturers

    • 2.1 Global Conjugate Vaccine Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Conjugate Vaccine Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Conjugate Vaccine Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Conjugate Vaccine Manufacturing Sites, Area Served, Product Type
    • 2.5 Conjugate Vaccine Market Competitive Situation and Trends
      • 2.5.1 Conjugate Vaccine Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Conjugate Vaccine Players (Opinion Leaders)

    3 Conjugate Vaccine Retrospective Market Scenario by Region

    • 3.1 Global Conjugate Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Conjugate Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Conjugate Vaccine Market Facts & Figures by Country
      • 3.3.1 North America Conjugate Vaccine Sales by Country
      • 3.3.2 North America Conjugate Vaccine Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Conjugate Vaccine Market Facts & Figures by Country
      • 3.4.1 Europe Conjugate Vaccine Sales by Country
      • 3.4.2 Europe Conjugate Vaccine Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Conjugate Vaccine Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Conjugate Vaccine Sales by Region
      • 3.5.2 Asia Pacific Conjugate Vaccine Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Conjugate Vaccine Market Facts & Figures by Country
      • 3.6.1 Latin America Conjugate Vaccine Sales by Country
      • 3.6.2 Latin America Conjugate Vaccine Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Conjugate Vaccine Sales by Country
      • 3.7.2 Middle East and Africa Conjugate Vaccine Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Conjugate Vaccine Historic Market Analysis by Type

    • 4.1 Global Conjugate Vaccine Sales Market Share by Type (2015-2020)
    • 4.2 Global Conjugate Vaccine Revenue Market Share by Type (2015-2020)
    • 4.3 Global Conjugate Vaccine Price Market Share by Type (2015-2020)
    • 4.4 Global Conjugate Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Conjugate Vaccine Historic Market Analysis by End Users

    • 5.1 Global Conjugate Vaccine Sales Market Share by End Users (2015-2020)
    • 5.2 Global Conjugate Vaccine Revenue Market Share by End Users (2015-2020)
    • 5.3 Global Conjugate Vaccine Price by End Users (2015-2020)

    6 Company Profiles and Key Figures in Conjugate Vaccine Business

    • 6.1 Pfizer
      • 6.1.1 Corporation Information
      • 6.1.2 Pfizer Description, Business Overview and Total Revenue
      • 6.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Pfizer Products Offered
      • 6.1.5 Pfizer Recent Development
    • 6.2 GSK
      • 6.2.1 GSK Conjugate Vaccine Production Sites and Area Served
      • 6.2.2 GSK Description, Business Overview and Total Revenue
      • 6.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 GSK Products Offered
      • 6.2.5 GSK Recent Development
    • 6.3 Sanofi
      • 6.3.1 Sanofi Conjugate Vaccine Production Sites and Area Served
      • 6.3.2 Sanofi Description, Business Overview and Total Revenue
      • 6.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Sanofi Products Offered
      • 6.3.5 Sanofi Recent Development
    • 6.4 Merck
      • 6.4.1 Merck Conjugate Vaccine Production Sites and Area Served
      • 6.4.2 Merck Description, Business Overview and Total Revenue
      • 6.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Merck Products Offered
      • 6.4.5 Merck Recent Development
    • 6.5 Walvax Biotechnology
      • 6.5.1 Walvax Biotechnology Conjugate Vaccine Production Sites and Area Served
      • 6.5.2 Walvax Biotechnology Description, Business Overview and Total Revenue
      • 6.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Walvax Biotechnology Products Offered
      • 6.5.5 Walvax Biotechnology Recent Development
    • 6.6 Royal (Wuxi) Bio-Pharmaceutical
      • 6.6.1 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Production Sites and Area Served
      • 6.6.2 Royal (Wuxi) Bio-Pharmaceutical Description, Business Overview and Total Revenue
      • 6.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Royal (Wuxi) Bio-Pharmaceutical Products Offered
      • 6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
    • 6.7 Bharat Biotech
      • 6.6.1 Bharat Biotech Conjugate Vaccine Production Sites and Area Served
      • 6.6.2 Bharat Biotech Description, Business Overview and Total Revenue
      • 6.6.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Bharat Biotech Products Offered
      • 6.7.5 Bharat Biotech Recent Development
    • 6.8 Zhifei Biologic
      • 6.8.1 Zhifei Biologic Conjugate Vaccine Production Sites and Area Served
      • 6.8.2 Zhifei Biologic Description, Business Overview and Total Revenue
      • 6.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Zhifei Biologic Products Offered
      • 6.8.5 Zhifei Biologic Recent Development

    7 Conjugate Vaccine Manufacturing Cost Analysis

    • 7.1 Conjugate Vaccine Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Conjugate Vaccine
    • 7.4 Conjugate Vaccine Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Conjugate Vaccine Distributors List
    • 8.3 Conjugate Vaccine Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Conjugate Vaccine Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Conjugate Vaccine by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Conjugate Vaccine by Type (2021-2026)
    • 10.2 Conjugate Vaccine Market Estimates and Projections by End Users
      • 10.2.1 Global Forecasted Sales of Conjugate Vaccine by End Users (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Conjugate Vaccine by End Users (2021-2026)
    • 10.3 Conjugate Vaccine Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Conjugate Vaccine by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Conjugate Vaccine by Region (2021-2026)
    • 10.4 North America Conjugate Vaccine Estimates and Projections (2021-2026)
    • 10.5 Europe Conjugate Vaccine Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Conjugate Vaccine Estimates and Projections (2021-2026)
    • 10.7 Latin America Conjugate Vaccine Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Conjugate Vaccine Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Conjugate Vaccine market is valued at US$ 9415 million in 2020 is expected to reach US$ 11700 million by the end of 2026, growing at a CAGR of 3.2% during 2021-2026.
      This report focuses on Conjugate Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Conjugate Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Southeast Asia and India etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by End Users. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Conjugate Vaccine market is segmented into
      Hib Vaccine
      Meningococcal Vaccine
      Pneumococcal Vaccine
      Others

      Segment by End Users
      Children
      Adult

      Global Conjugate Vaccine Market: Regional Analysis
      The Conjugate Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by End Users segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Conjugate Vaccine market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Conjugate Vaccine Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Conjugate Vaccine market include:
      Pfizer
      GSK
      Sanofi
      Merck
      Walvax Biotechnology
      Royal (Wuxi) Bio-Pharmaceutical
      Bharat Biotech
      Zhifei Biologic

      Buy now